P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
Main Authors: | Sjoerd Hermans, Yvette van Norden, Erik van Werkhoven, Avinash Dinmohamed, Peter Huijgens, Gert Ossenkoppele, Gerwin Huls, Bob Löwenberg, Thomas Pabst, Dimitri Breems, Douwe Postmus, Francesco Pignatti, Jurjen Versluis, Jan Cornelissen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000969164.32364.1c |
Similar Items
-
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
by: Niek G. van der Maas, et al.
Published: (2024-03-01) -
The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed
by: Katerina Bakunina, et al.
Published: (2022-02-01) -
P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
by: Jesse Tettero, et al.
Published: (2023-08-01) -
P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B-ALL IN ADULTS. A PHASE II HOVON TRIAL
by: A. Rijneveld, et al.
Published: (2022-06-01) -
Allogeneic stem cell transplantation and minimal residual disease in patients with AML in first complete remission
by: Jurjen Versluis, et al.
Published: (2018-06-01)